Brandon Capital Partners
Venture Capital Accelerator Est. 2007
USD 500M
Estimated FUM
- Type
- Venture Capital
- HQ
- Melbourne, VIC, Australia
- Founded
- 2007
- Focus
- Life Sciences · Healthcare & Life Sciences
About
Brandon Capital Partners (Brandon Capital) is a life-sciences venture capital firm investing from seed through expansion capital and managing Brandon BioCatalyst, a life-science investment collaboration.
Strategies
Venture Capital
Investment Focus
Sources
Profile sources
- brandoncapital.vc — Life Sciences, Healthcare & Life Sciences
- brandoncapital.vc — Life Sciences, Healthcare & Life Sciences
Locations & investment markets
Office · Melbourne, Australia
Office · Sydney, Australia
Office · London, United Kingdom
Office · United States
Headquarters · Australia
Reported capital
AUD 439M · Fund size
Brandon BioCatalyst Fund Six (BB6) · reported 2025-07-24
≥AUD 1B · Cumulative capital raised
Venture manager · reported 2025-07-24
Capital and location details checked 2026-10-14.
Investment Criteria
Investment size
USD 500K - USD 15M
Reported investment size. Actual commitments may vary by stage, ownership and follow-on participation.
Investment Stages
Stages
Seed Series A Series B Growth
Investment Geographies
Primary Markets
Australia United Kingdom
Coverage
Country-focused Regions
Oceania Europe
Coverage is a guide only.
Location
Office Presence
2 countries
Australia United Kingdom
3 known offices
Melbourne, VIC, Australia (HQ)
Sydney, NSW, Australia
London, United Kingdom
Deals & Activity
Deals, last 12 months
3
1 led
Deals, last 36 months
15
1 led
Exits, last 36 months
1
1 on record
Recent deals
Rounds, buyouts and stakes from public sources · How this is counted- Cadmus Animal Health LeadFunding round · Oct 2026With Movac, Booster, Digitalis Ventures and 1 more
- Series D · Jul 2026With Ally Bridge Group (lead), Alpha Wave (lead), Bain Capital and 9 moreUS$315m
- A$27m
- A$28m
- Series B · Oct 2025With Uniseed, Stoic Venture Capital, Gates Foundation and 1 moreUS$22.4m
- Series B · Sep 2025With SV Health Investors (lead), British Business Bank, M Ventures and 4 more£50m
- A$4.5m
- Series D · Jun 2025With Lightstone Ventures (lead), ClavystBio (lead), WTT investment (lead) and 8 moreUS$57.5m
Exits
- Myricx Bio · sold to Novartis Jul 2026
Tracked deals
15
Most common deal types
Series B (6) Growth (5) Unknown (2) Series A (1) Seed (1)
Similar investors
OneVentures
OneVentures is an Australian investment manager with technology growth-equity and clinical-stage life-sciences investment pillars, alongside a growth-credit practice providing debt facilities to technology companies.
OIF Ventures
We're a leading Australian venture capital firm that champions exceptional founders, driven by purpose, who add material value to their customers, markets, and communities. We invest in early stage companies with innovative, high-growth and disruptive technologies and have deep conviction in the power of technology founders and give our all to make them succeed.
Blackbird Ventures
Blackbird is an Australia and New Zealand venture capital firm backing ambitious technology companies from the earliest stages through later growth. It invests across software, deep tech, climate, fintech, health and other technology-led sectors, with portfolio companies including Canva, SafetyCulture, Culture Amp, Zoox and Halter.
Equity Venture Partners (EVP)
Equity Venture Partners is an early-stage venture capital firm investing in B2B software companies across Australia and New Zealand.
Era VC
Consumer-focused venture capital firm investing in transformative consumer brands across Australia, North America, and Europe; HQ in Melbourne, Australia; invests from seed to growth stages.
Reinventure Group
Reinventure Group independently operates a venture fund investing in early businesses focused on financial-services technology and adjacent industries; Westpac is the fund's largest investor.
Other Venture Capital Firms in Melbourne
Square Peg Capital
Square Peg is a venture capital firm that invests in emerging technology companies across the internet economy in Australia and New Zealand, Southeast Asia, and Israel.
Uniseed
Uniseed manages Commercialisation and Venture Funds that invest in companies commercialising research from university and research partners, including early-stage deep-tech and life-sciences businesses.
Rampersand
rampersand is an early-stage venture capital firm. We invest in the best Australian technology founders, teams and companies and are committed to helping them become major national, regional and global leaders.
The rampersand team has worked with successful startups and technology firms in Australia, Silicon Valley, Israel, Europe and Asia. Our partners have seen numerous companies from the early stages through to successful exits including BEA Systems (acquired by Oracle for US$7.2bn), Jajah (acquired by Telefonica), Snaptu (acquired by Facebook), Onavo (acquired by Facebook), StepStone (acquired by Axel Springer) and Amobee (acquired by Singtel for over US$300m).
Giant Leap Fund
Giant Leap is an impact venture capital investor. It invests in companies harnessing technology and innovation to reimagine industries and create transformational change across climate, health and people, backing mission-driven founders from pre-seed to Series A.
Constant Innovation
Constant Innovation is an early-stage venture capital firm based in Australia that invests in high-growth technology businesses.
Startmate
Startmate is an accelerator and venture investor that operates a pre-seed fund for Accelerator cohorts and a follow-on continuity fund for selected alumni.